Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26007236
DOI
10.1016/j.biocel.2015.05.012
PII: S1357-2725(15)00133-8
Knihovny.cz E-zdroje
- Klíčová slova
- Breast adenocarcinoma MDA-MB-231 cells, Breast carcinoma HTB-126 cells, Hypoxia, NADPH-dependent isocitrate dehydrogenase IDH2, Oncometabolite r-2-hydroxyglutarate, Reductive carboxylation,
- MeSH
- glutaráty metabolismus MeSH
- hypoxie buňky fyziologie MeSH
- isocitrátdehydrogenasa genetika metabolismus MeSH
- kyslík metabolismus MeSH
- lidé MeSH
- nádorové biomarkery genetika metabolismus MeSH
- nádorové buněčné linie MeSH
- nádory prsu enzymologie genetika metabolismus MeSH
- parciální tlak MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- alpha-hydroxyglutarate MeSH Prohlížeč
- glutaráty MeSH
- IDH2 protein, human MeSH Prohlížeč
- isocitrátdehydrogenasa MeSH
- kyslík MeSH
- nádorové biomarkery MeSH
Mitochondrial NADPH-dependent isocitrate dehydrogenase, IDH2, and cytosolic IDH1, catalyze reductive carboxylation of 2-oxoglutarate. Both idh2 and idh1 monoallelic mutations are harbored in grade 2/3 gliomas, secondary glioblastomas and acute myeloid leukemia. Mutant IDH1/IDH2 enzymes were reported to form an oncometabolite r-2-hydroxyglutarate (2HG), further strengthening malignancy. We quantified CO2-dependent reductive carboxylation glutaminolysis (RCG) and CO2-independent 2HG production in HTB-126 and MDA-MB-231 breast carcinoma cells by measuring (13)C incorporation from 1-(13)C-glutamine into citrate, malate, and 2HG. For HTB-126 cells, (13)C-citrate, (13)C-malate, and (13)C-2-hydroxyglutarate were enriched by 2-, 5-, and 15-fold at 5mM glucose (2-, 2.5-, and 13-fold at 25 mM glucose), respectively, after 6 h. Such enrichment decreased by 6% with IDH1 silencing, but by 30-50% upon IDH2 silencing while cell respiration and ATP levels rose up to 150%. Unlike 2HG production RCG declined at decreasing CO2. At hypoxia (5% O2), IDH2-related and unrelated (13)C-accumulation into citrate and malate increased 1.5-2.5-fold with unchanged IDH2 expression; whereas hypoxic 2HG formation did not. (13)C-2HG originated by ∼50% from other than IDH2 or IDH1 reactions, substantiating remaining activity in IDH1&2-silenced cells. Relatively high basal (12)C-2HG levels existed (5-fold higher vs. non-tumor HTB-125 cells) and (13)C-2HG was formed despite the absence of any idh2 and idh1 mutations in HTB-126 cells. Since RCG is enhanced at hypoxia (frequent in solid tumors) and 2HG can be formed without idh1/2 mutations, we suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients.
Citace poskytuje Crossref.org
Carbon Monoxide-Releasing Activity of Plant Flavonoids
Mitochondrial Physiology of Cellular Redox Regulations
Biochemical Background in Mitochondria Affects 2HG Production by IDH2 and ADHFE1 in Breast Carcinoma
The Effects of Bilirubin and Lumirubin on Metabolic and Oxidative Stress Markers
2-Hydroxyglutarate in Cancer Cells
Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells